- Home
- A-Z Publications
- Recent Patents on Drug Delivery & Formulation
- Previous Issues
- Volume 14, Issue 1, 2020
Recent Patents on Drug Delivery & Formulation - Volume 14, Issue 1, 2020
Volume 14, Issue 1, 2020
-
-
Next Steps in 3D Printing of Fast Dissolving Oral Films for Commercial Production
Authors: Touraj Ehtezazi, Marwan Algellay and Alison Hardy3D printing technique has been utilised to develop novel and complex drug delivery systems that are almost impossible to produce by employing conventional formulation techniques. For example, this technique may be employed to produce tablets or Fast Dissolving oral Films (FDFs) with multilayers of active ingredients, which are personalised to patient’s needs. In this article, we compared the production of FDFs by 3D pr Read More
-
-
-
Fast Dissolving/Disintegrating Dosage Forms of Natural Active Compounds and Alternative Medicines
Authors: Anupama Singh, Vandana Kharb and Vikas A. SaharanFast Dissolving/Disintegrating Dosage Forms (FDDFs) are a group of dosage forms which dissolve or disintegrate quickly, leading to fast distribution of active ingredients at the site of administration; thereby providing ease of oral ingestion of solid unit dosage forms and have the potential to enhance transmucosal absorption. With time, the use of FDDFs in alternative systems has significantly increased. Homeopathic systems Read More
-
-
-
Development of the Modified Ocimum gratissimum Seeds for Orally Disintegrating Tablets
Authors: Yen N.T. Dang, Phuong H.L. Tran and Thao T.D. TranBackground: Natural materials have been encouraged in controlled drug release and improved drug bioavailability. Objective: This study aimed to develop a modification process for the use of a natural material, Ocimum gratissimum seeds (OGS), in Orally Disintegrating Tablets (ODTs). Methods: The OGS was investigated with four different modification processes including only milling, swelling, swelling/milling, and swelli Read More
-
-
-
Formulation and in vitro Evaluation of Fast Dissolving Tablets of Febuxostat Using Co-Processed Excipients
Authors: Manpreet Kaur, Amit Mittal, Monica Gulati, Deepika Sharma and Rajesh KumarBackground: Febuxostat is a novel, orally-administered, powerful, non-purine, xanthine oxidase inhibitor used for treating gout and ceaseless tophaceous gout. The drug exhibits low bioavailability (about 49%) which is ascribed to its dissolution rate-limited absorption. Objective: The current work is aimed to provide a novel strategy to improve the dissolution profile and thus, the bioavailability of Febuxostat. Methods: Formula Read More
-
-
-
An Overview on Recent Patents and Technologies on Solid Dispersion
Authors: Ritu Kaushik, Vikas Budhwar and Deepak KaushikThe oral bioavailability enhancement of poorly water-soluble medicaments is still one of the most complicated aspects of the formulation development. Various approaches are currently available for solubility and rate of dissolution enhancement such as salt formation, solubilization and reduction of particle size, each with its own limitations and advantages. Solid dispersion is one of the most suitable approaches for t Read More
-
-
-
Effect of Ultrasound Intensity and Mode on Piroxicam Transport Across Three-Dimensional Skin Equivalent Epiderm™
More LessBackground: Transdermal drug delivery has many advantages compared to other routes. However, the barrier function of the stratum corneum limits the use of the skin as an administrative route for medications. Different methods were investigated to alter the barrier function of the stratum corneum and it was found that applying different ultrasound waves could enhance the skin's permeability. Objective: The aim of Read More
-
Most Read This Month
Article
content/journals/ddf
Journal
10
5
false
en
